The hierarchical diagnosis and treatment system's two-way referral mechanism is crucial for optimizing medical resource allocation, with medical consortia significantly enhancing this process. It evaluates the implementation dynamics of two-way referral systems within China's medical consortia from 2019 to 2024, focusing on policy evolution, regional disparities, and stakeholder engagement. Despite a positive overall trend, referral rates remain low, with notable regional and institutional disparities. The implementation outcomes span various dimensions, including referral metrics, specific services, timing, and costs; however, these effects are inconsistent and warrant further investigation. The current evaluation index system is diverse but tends to prioritize quantity over quality. Additionally, awareness and satisfaction levels among medical personnel and patients regarding the two-way referral system are uneven and influenced by multiple factors. Currently, China's two-way referral system faces challenges, including low referral volumes, an inadequate evaluation framework, limited research perspectives, and insufficient motivation for stakeholder participation. Future efforts should focus on strengthening primary care infrastructure, enhancing resource collaboration, advancing health insurance reforms, refining the evaluation system, and fostering synergy between hierarchical diagnosis and treatment, the Healthy China strategy, and referral model innovation to advance the hierarchical diagnosis and treatment system. Recommendations emphasize strengthening primary care capacity, reforming insurance payment models, and leveraging digital health technologies to align with the “Healthy China 2030” strategic goals.
| [1] |
L. K. Kearney, A. M. Zeiss, M. A. McCabe, et al., “Global Approaches to Integrated Care: Best Practices and Ongoing Innovation,” American Psychologist 75, no. 5 (2020): 668–682.
|
| [2] |
A. D. M. Briggs, A. Göpfert, R. Thorlby, D. Allwood, and H. Alderwick, “Integrated Health and Care Systems in England: Can They Help Prevent Disease?,” Integrated Healthcare Journal 2, no. 1 (2020): e000013.
|
| [3] |
S. Sandhu, A. Sharma, R. Cholera, and J. P. Bettger, “Integrated Health and Social Care in the United States: A Decade of Policy Progress,” International Journal of Integrated Care 21, no. 4 (2021): 9.
|
| [4] |
C. Lu, Z. Zhang, and X. Lan, “Impact of China's Referral Reform on the Equity and Spatial Accessibility of Healthcare Resources: A Case Study of Beijing,” Social Science & Medicine 235 (2019): 112386.
|
| [5] |
W. Yip and W. Hsiao, “Harnessing the Privatization of China's Fragmented Healthcare Delivery,” The Lancet 384, no. 9945 (2014): 805–818.
|
| [6] |
People's Republic of China Central People's Government. “National Health Commission Answers Questions on Tiered Diagnosis and Treatment System and System Construction.” (Accessed Sep 2025), https://www.gov.cn/xinwen/2021-07/23/content_5626971.htm.
|
| [7] |
People's Republic of China Central People's Government. “Using Medical Consortium to Solve the Pain of People's Medical Treatment.” (Accessed Sep 2025), https://www.gov.cn/xinwen/2021-07/24/content_5627034.htm.
|
| [8] |
H. Gao, X. Du, J. Liao, and L. Xiang, “The Pathway of China's Integrated Delivery System: Based on the Analysis of the Medical Consortium Policies,” Current Medical Science 42, no. 6 (2022): 1164–1171.
|
| [9] |
People's Republic of China Central People's Government. “Opinions on Further Improving the Medical and Health Service System.” (Accessed Sep 2025), https://www.gov.cn/gongbao/content/2023/content_5750620.htm.
|
| [10] |
People's Republic of China Central People's Government. “Opinions on Deepening the Reform of the Medical and Health System.” (Accessed Sep 2025), https://www.gov.cn/gongbao/content/2009/content_1284372.htm.
|
| [11] |
People's Republic of China Central People's Government. “Guiding Opinions on Promoting the Construction of the Tiered Diagnosis and Treatment System.” (Accessed Sep 2025), https://www.gov.cn/gongbao/content/2015/content_2937321.htm.
|
| [12] |
People's Republic of China Central People's Government. “Guiding Opinions on Promoting the Construction and Development of Medical Consortium.” (Accessed Sep 2025), https://www.gov.cn/zhengce/zhengceku/2017-04/26/content_5189071.htm.
|
| [13] |
People's Republic of China Central People's Government. “Notice on Issuing the Management Measures for Medical Consortium (Trial).” (Accessed Sep 2025), https://www.gov.cn/gongbao/content/2020/content_5554582.htm.
|
| [14] |
People's Republic of China Central People's Government. “A Total of 18,000 Medical Consortium of Various Forms Have Been Established Nationwide.” (Accessed Sep 2025), https://www.gov.cn/lianbo/bumen/202402/content_6934829.htm.
|
| [15] |
D. Zhao, S. Chen, S. Jin, et al., “Predictors of Referral Behaviour and Intention amongst Physicians in a Medical Consortium Based on the Theory of Planned Behaviour: A Cross-Sectional Study in China,” Frontiers in Public Health 11 (2023): 1159207.
|
| [16] |
Z. Wei, J. Bai, and R. Feng, “Optimization Referral Rate Design for Hierarchical Diagnosis and Treatment System Based on Accessibility-Utilization Efficiency Bi-objective Collaboration: A Case Study of China,” Social Science & Medicine 322 (2023): 115827.
|
| [17] |
X. Li and Y. Li, “Structural Analysis of the Growth of Medical Expenses in Public Hospitals Within the Medical Consortium in Sanming City,” Chinese Health Economics 40, no. 1 (2021): 30–35.
|
| [18] |
Y. Lei, Y. Zhao, and J. Sun, “Analysis of the Current Situation and Influencing Factors of Two-Way Referral of Community Residents in Haidian District, Beijing Under the Medical Consortium Model,” Chinese General Practice 22, no. 25 (2019): 3049–3054.
|
| [19] |
P. Tian, Z. Wang, and R. Chen, “Analysis of the Construction Status of Medical Consortium-Taking Bozhou City, Anhui Province as an Example,” Health Soft Science 35, no. 8 (2021): 14–18.
|
| [20] |
M. Cai, E. Liu, H. Tao, et al., “Does a Medical Consortium Influence Health Outcomes of Hospitalized Cancer Patients? An Integrated Care Model in Shanxi, China,” International Journal of Integrated Care 18, no. 2 (2018): 7.
|
| [21] |
L. Xu, N. Xu, X. Jiang, et al., “Study on the Evaluation and Influencing Factors of Contracted Residents on the Coordination of Primary Medical Institutions,” Frontiers in Public Health 12 (2024): 1307765.
|
| [22] |
X. Huang, J. Hu, S. Hu, and L. He, “Analysis of the Current Situation of Two-Way Referral in Shenzhen From the Perspective of Regional Medical Consortium,” Chinese Hospital Management 42, no. 9 (2022): 43–45.
|
| [23] |
Y. Qin, X. Wang, Y. Yang, Z. Zheng, and J. Su, “Application Effect of Precise Referral Mode in Community Health Service Centers Under the Medical Consortium,” Chinese Rural Health 14, no. 5 (2022): 31–32. +37.
|
| [24] |
F. Gong, J. Luo, Z. Wang, et al., “Network Characteristics of Referrals for Chronic Disease Patients: Results From Hierarchical Medical Reform in Shenzhen, China,” BMC Public Health [Electronic Resource] 24, no. 1 (2024): 3600.
|
| [25] |
P. Lu, Y. Ji, H. Qu, et al., “19P Referral Patterns Among Breast Cancer Patients in County-Level Hospitals in China,” Annals of Oncology 34 (2023): S1474.
|
| [26] |
G. Cheng, W. Pan, X. Wang, et al., “The Impact of Medical Consortium Construction Management System on Doctors' Vertical Cooperation Willingness and Behavior,” Chinese Hospital Management 42, no. 9 (2022): 6–11.
|
| [27] |
X. Yu, L. Xiang, H. Zhou, K. Tang, and D. Lv, “Investigation and Countermeasure Analysis of the Current Situation of Two-Level Regional Medical Consortium in Ningbo City,” Chinese Hospital Management 39, no. 8 (2019): 29–31.
|
| [28] |
X. Yang and S. Zhang, “Analysis of the Construction and Application Status of Hospital Regional Information System in Beijing,” Chinese Digital Medicine 16, no. 3 (2021): 104–108.
|
| [29] |
L. M. Jin, L. Xu, J. Xu, et al., “Effects of Information Technology-Based Two-Way Referral on Diagnosis and Management of Cervical Lesions: A Cluster-Controlled Trial in China,” Asia Pacific Journal of Public Health 30, no. 5 (2018): 491–499.
|
| [30] |
B. Zhang, R. Xu, L. Chen, et al., “Current Situation and Countermeasures of Maternal and Child Health Care Institutions' Rescue Capacity Based on Medical Consortium Platform in Anhui Province,” Chinese Hospitals 26, no. 6 (2022): 29–32.
|
| [31] |
L. Bai, Y. Cheng, Z. Tao, L. Feng, S. Wang, and Y. Zeng, “Research on Maternal Service Area and Referral System in Hubei Province, China,” International Journal of Environmental Research and Public Health 19, no. 8 (2022): 4881.
|
| [32] |
F. Yan, H. Chen, J. Li, G. Shi, W. Xu, and B. Zhou, “Evaluation of the Implementation Effect of Two-way Referral for Coronary Heart Disease Patients in Medical Consortium,” Chinese Hospitals 19, no. 8 (2015): 46–47.
|
| [33] |
G. Shi, B. Zhou, Z. C. Cai, T. Wu, X. F. Li, and W. Xu, “Referral by Outreach Specialist Reduces Hospitalization Costs of Rural Patients With Digestive Tract Cancer: A Report From Medical Consortium in China,” Rural and Remote Health 14 (2014): 7–16.
|
| [34] |
S. Li, S. Shi, H. Chen, D. Liu, and N. Wang, “Empirical Analysis of the Operation Effect of Two-way Referral System From the Perspective of Medical Consumers,” Chinese Health Policy Research 10, no. 7 (2017): 22–27.
|
| [35] |
Y. Pang, N. Cheng, X. Yang, J. Yang, and H. Liu, “Analysis of the Characteristics of Two-Way Referral Inpatients in a Tertiary Hospital From 2015 to 2019,” Chinese Medical Records 22, no. 7 (2021): 67–70.
|
| [36] |
S. Yuan, F. Fan, and D. Zhu, “Effects of Vertical Integration Reform on Primary Healthcare Institutions in China: Evidence From a Longitudinal Study,” International Journal of Health Policy and Management 11, no. 9 (2021): 1835–1843.
|
| [37] |
S. Yuan, F. Wang, Y. Zhao, and Y. Liu, “Assessing Perceived Quality of Primary Care Under Hospital-Township Health Centre Integration: A Cross-Sectional Study in China,” The International Journal of Health Planning and Management 35, no. 1 (2020): e196–e209.
|
| [38] |
Y. Zhou, L. Yuan, L. Wu, S. Li, and S. Dong, “Construction and Application Effect Evaluation of Palliative Care Tiered Referral Service System,” Chinese Nursing Management 24, no. 5 (2024): 675–680.
|
| [39] |
X. Song, Y. Li, Q. Zhao, et al., “Application Effect Evaluation of Two-Way Referral Service in the Transfer and Treatment of Coronary Heart Disease Patients,” Chinese Journal of Health Management 17, no. 2 (2023): 130–135.
|
| [40] |
L. Tang, Q. Liang, M. Liu, F. Xie, and Z. Guo, “Evaluation of the Impact of DRG Policy on the Effect of Tertiary Hospitals' Tiered Diagnosis and Treatment,” Chinese Hospitals 29, no. 2 (2025): 50–55.
|
| [41] |
M. Wu, X. Tian, and Y. Xin, “Evaluation of the Effect of Tiered Diagnosis and Treatment in Urban Vertical Medical Consortium Based on Weighted TOPSIS Method,” Medical Education Management 10, no. 2 (2024): 209–214.
|
| [42] |
T. Hu, C. Wu, X. Tian, and Y. Xin, “Research on the Effect and Influencing Factors of Tiered Diagnosis and Treatment in Beijing Medical Consortium,” Chinese Hospital Management 44, no. 1 (2024): 47–52.
|
| [43] |
D. Luo, X. Li, and C. Gong, “Construction of a Tiered Diagnosis and Treatment Performance Evaluation Model Based on Grounded Theory and Structural Equation,” Chinese Hospitals 27, no. 7 (2023): 31–35.
|
| [44] |
B. Zhu, X. Han, Y. Huang, S. Ou, and L. Ren, “Assessment of Primary Medical Service Capacity in Close Medical Consortium: Taking Dapeng New District Medical and Health Group as an Example,” Chinese Health Quality Management 30, no. 5 (2023): 105–110.
|
| [45] |
T. Lin and C. Tang, “Construction of Evaluation Index System for Medical and Elderly Care Integration Services Under Regional Medical Consortium,” Medicine and Society 35, no. 11 (2022): 38–43.
|
| [46] |
F. Yao, G. Xiang, Y. Xia, L. Shi, and D. Wang, “Evaluation Study on the Reform Effect of Medical Consortium Construction in a Province,” Health Economics Research 38, no. 3 (2021): 24–28.
|
| [47] |
J. Xiong, X. Song, and Y. Bai, “Construction of Sustainable Development Evaluation Index System for Medical Consortium-Based on the Delphi Method,” Health Economics Research 38, no. 3 (2021): 59–62.
|
| [48] |
C. Liu, J. Gao, J. Xiao, et al., “Research on the Performance Evaluation of Medical Consortium in Cities and Counties in China,” Chinese Hospital Management 41, no. 2 (2021): 18–22.
|
| [49] |
M. Wang, H. Fang, and H. Tao, “Research on the Screening of Performance Evaluation Indexes for Vertical Close Medical Consortium,” Chinese General Practice 23 (2020): 3533–3539.
|
| [50] |
G. Zhang, F. Wang, and P. Zhang, “Evaluation of the Operation Effect of Loose Medical Consortium Based on DRGs,” Health Soft Science 34, no. 3 (2020): 14–18.
|
| [51] |
Z. Gao, L. Xiang, and Y. Huang, “Current Situation and Research on Tiered Diagnosis and Treatment Under Medical Consortium Construction in a District of Shanghai,” Modern Hospital Management 22, no. 5 (2024): 1–4.
|
| [52] |
W. Yu, M. Li, X. Nong, et al., “Practices and Attitudes of Doctors and Patients to Downward Referral in Shanghai, China,” BMJ Open 7, no. 4 (2017): e012565.
|
| [53] |
Z. Luo and L. Liu, “Investigation on the Perception of Doctors and Patients to Two-Way Referral in a Medical Consortium in Chongqing,” Chinese General Practice 23, no. 12 (2020): 1535–1540.
|
| [54] |
K. Wu, Y. Zheng, Y. Wan, S. Yang, and Z. Yang, “Investigation on the Service Demand and Utilization Status and Effect Evaluation of Medical Consortium Among Medical Staff in Sichuan Province,” Chinese Journal of Public Health 36, no. 10 (2020): 1406–1408.
|
| [55] |
N. Wang and J. Xiao, “Analysis of the Current Situation and Influencing Factors of Two-Way Referral in a Medical Consortium in Guangdong Province-Based on Survey Data,” Chinese Rural Health Affairs Management 41, no. 1 (2021): 38–43.
|
| [56] |
H. Dong, X. Huang, H. Liang, K. Ji, and R. Chen, “Study on the Perception and Satisfaction of Core Hospital Medical Staff in Anhui Province's Close Urban Medical Consortium on the Operation of Two-Way Referral,” Anhui Medical Journal 45, no. 1 (2024): 100–105.
|
| [57] |
L. Zhang, W. Hai, and J. Li, “Survey and Analysis of the Perception of Two-Way Referral Among Residents and Medical Staff Under the Framework of County Medical Community—Taking Yingquan District Medical Community as an Example,” Chinese Rural Health 16, no. 3 (2024): 20–22.
|
| [58] |
Y. Chen, P. Jiang, S. Liu, et al., “Investigation on the Participation of Medical Staff in Medical Consortium Work and the Evaluation of Medical Consortium Effect,” Health Economics Research 39, no. 7 (2022): 10–14.
|
| [59] |
D. Li, “Evaluation of the Effect of Tiered Diagnosis and Treatment in Beijing's Vertical Medical Consortium Based on Medical Staff Perception,” Continuing Medical Education 38, no. 9 (2024): 163–166.
|
| [60] |
H. Gao, J. Zhao, T. Xu, et al., “Investigation on the Awareness of Medical Consortium Policy Among Medical Staff in Guangxi's “Three-Two Medical Consortium”,” Health Soft Science 36, no. 5 (2022): 12–16.
|
| [61] |
J. Wei, M. Ge, Z. Liu, Y. Zhao, X. Liu, and B. Chen, “Implementation Status and Analysis of Two-Way Referral System in Luohe City Under Medical Consortium Model,” Chinese General Practice 20, no. 4 (2022): 635–638.
|
| [62] |
Z. Xiong, W. Zhang, and X. Du, “Research on the Implementation Status and Effect of “Medical Consortium” Model Under Tiered Diagnosis and Treatment System,” Chinese Health Affairs Management 37, no. 4 (2020): 248–251.
|
| [63] |
X. Jing, L. Xu, W. Qin, et al., “The Willingness for Downward Referral and Its Influencing Factors: A Cross-Sectional Study Among Older Adults in Shandong, China,” International Journal of Environmental Research and Public Health 17, no. 1 (2020): 369.
|
| [64] |
D. Feng, D. Zhang, B. Li, et al., “Does Having a Usual Primary Care Provider Reduce Patient Self-Referrals in Rural China's Rural Multi-Tiered Medical System? A Retrospective Study in Qianjiang District, China,” BMC Health Services Research 17, no. 1 (2017): 778.
|
| [65] |
G. Ji, L. Hu, M. Shi, and Y. Zhu, “Analysis of the Implementation Status of Tiered Diagnosis and Treatment System in a District of Shanghai,” Chinese Health Resources 19, no. 4 (2016): 315–317. +322.
|
| [66] |
M. Yu, Z. Yang, C. Jiang, and L. Shi, “Relationship Between Outpatients' sociodemographic and Belief Characteristics and Their Healthcare-Seeking Behavioral Decision-Making: Evidence From Jiaxing City, China,” PLoS ONE 17 (2022): e0270340.
|
| [67] |
X. Wen, Q. Song, S. OuYang, Z. Yao, and Y. Luo, “Novel Use of Structural Equation Modeling to Examine the Development of a Framework of Patient-Centered Two-Way Referral Systems for Building Digital Subjective Well-Being Healthcare: A Cross-Sectional Survey in Central China,” Digital Health 10 (2024): 20552076241253079.
|
| [68] |
X. Li, H. M. Krumholz, W. Yip, et al., “Quality of Primary Health Care in China: Challenges and Recommendations,” The Lancet 395, no. 10239 (2020): 1802–1812.
|
RIGHTS & PERMISSIONS
2025 The Author(s). Journal of Evidence-Based Medicine published by Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.
PDF
